Gainers & Losers
Thu Dec 11 2025 09:55:57- Eternal share price
- ₹290.852.65%
- Tata Steel share price
- ₹166.352.56%
- Kotak Mahindra Bank share price
- ₹2,175.452.17%
- Maruti Suzuki India share price
- ₹16,229.001.41%
- UltraTech Cement share price
- ₹11,471.001.35%
Active Stocks
Thu Dec 11 2025 10:20:22- Yes Bank share price
- ₹21.940.97%
- Samvardhana Motherson Inte...
- ₹120.003.23%
- Suzlon Energy share price
- ₹52.060.93%
- Tata Power Company share price
- ₹379.750.04%
- State Bank of India share price
- ₹963.400.40%
Aarti Drugs Profit & Loss Annual
395.50 +5.35 (1.37%)Updated : 11 Dec 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 2,152.58 | 2,259.01 | 2,456.93 | 2,206.10 |
| Other Net | 0.30 | -3.36 | -3.41 | 4.56 |
| Diluted Weighted Average Shares | 9.16 | 9.19 | 9.26 | 9.26 |
| Gain( Loss)on Saleof Assets | 0.00 | -0.18 | - | 0.00 |
| Depreciation/ Amortization | 55.78 | 51.45 | 50.32 | 50.05 |
| Operating Income | 234.45 | 269.57 | 259.13 | 282.55 |
| Net Income | 168.16 | 171.42 | 166.31 | 205.04 |
| Income Availableto Com Excl Extra Ord | 168.16 | 171.42 | 166.31 | 205.04 |
| Other Operating Expenses Total | 9.37 | 9.11 | 9.14 | 7.26 |
| Net Income Before Taxes | 211.77 | 235.53 | 224.18 | 269.96 |
| Minority Interest | 0.06 | -0.17 | -0.05 | 0.04 |
| Net Income After Taxes | 168.10 | 171.59 | 166.36 | 205.00 |
| Income Availableto Com Incl Extra Ord | 168.16 | 171.42 | 166.31 | 205.04 |
| Costof Revenue Total | 1,857.86 | 1,996.95 | 2,201.43 | 1,967.42 |
| Gross Profit | 529.17 | 531.62 | 514.62 | 521.23 |
| Interest Inc( Exp) Net- Non- Op Total | -22.98 | -30.50 | -31.54 | -17.15 |
| Diluted Net Income | 168.16 | 171.42 | 166.31 | 205.04 |
| Provisionfor Income Taxes | 43.67 | 63.94 | 57.82 | 64.96 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 168.16 | 171.42 | 166.31 | 205.04 |
| Total Revenue | 2,387.03 | 2,528.58 | 2,716.05 | 2,488.65 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,387.03 | 2,528.58 | 2,716.05 | 2,488.65 |
| Selling/ General/ Admin Expenses Total | 216.53 | 193.15 | 191.38 | 177.01 |
| Diluted Normalized EPS | 18.35 | 18.66 | 17.96 | 22.14 |
| Research Development | 13.04 | 8.35 | 4.66 | 4.36 |
| Diluted EPS Excluding Extra Ord Items | 18.35 | 18.65 | 17.96 | 22.14 |
| DPS- Common Stock Primary Issue | - | 1.00 | 1.00 | 1.00 |
| Unusual Expense( Income) | - | - | - | 0.00 |
*All figures in crores except per share values
Aarti Drugs Quick Links
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Balance Sheet Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
290.85+7.50(2.65%)
166.35+4.15(2.56%)
2,175.45+46.15(2.17%)
2,778.50-26.15 (-0.93%)
2,052.40-14.30 (-0.69%)